EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $118.51 and last traded at $118.8610, with a volume of 24591 shares trading hands. The stock had previously closed at $123.37.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on ESLOY shares. Kepler Capital Markets upgraded EssilorLuxottica from a "hold" rating to a "buy" rating in a report on Thursday, January 15th. The Goldman Sachs Group restated a "buy" rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Citigroup reaffirmed a "buy" rating on shares of EssilorLuxottica in a report on Thursday, December 11th. UBS Group raised shares of EssilorLuxottica from a "hold" rating to a "strong-buy" rating in a report on Thursday, November 27th. Finally, Zacks Research downgraded shares of EssilorLuxottica from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, November 18th. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy".
Read Our Latest Stock Analysis on ESLOY
EssilorLuxottica Stock Performance
The company has a debt-to-equity ratio of 0.18, a current ratio of 0.97 and a quick ratio of 0.67. The firm has a fifty day moving average of $150.36 and a 200-day moving average of $161.94.
EssilorLuxottica Company Profile
(
Get Free Report)
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EssilorLuxottica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.
While EssilorLuxottica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.